MAPT and Alzheimer disease: In human AD brain slices, 2D6-2C6 immunoreactivity co-localizes with that of AT8 (see Fig. 3), which detects phosphorylated tau aggregates, indicating that tau 423–430 AA residues recognized by 2D6-2C6 are externally exposed during tau aggregation in human samples.